Weekly Market Movers

Weekly Market Movers:
Week Ending November 6, 2026

Technology fell 8.2% as energy dropped 12.0%; real estate and consumer discretionary led modest gains

Money365.Market Data Desk··5 trading days·1,910 stocks screened
Week at a glanceOct 30 → Nov 6
S&P 500 (SPY)
▼-2.69%
Nasdaq-100 (QQQ)
▼-4.98%
Russell 2000 (IWM)
▼-2.04%
Breadth (adv / dec)
934/961
49% advancing · median -0.05%
Best sector ETF Real Estate (XLRE) ▲+1.92% · Weakest Energy (XLE) ▼-12.00%

The Week in Brief

TL;DR
  • Nasdaq-100 fell 5.0% while the Dow Jones declined just 1.0%, with Technology down 8.2%
  • Energy dropped 12.0% as crude oil fell 12.1%; real estate and consumer discretionary each gained 1.9%
  • AppLovin Corporation rose 71.2% after an earnings beat; Veracyte, Inc. fell 51.7% despite beating estimates
  • Gold gained 4.7% while 20-year Treasuries added 0.1%; breadth was nearly balanced at 934 advancers versus 961 decliners

Major U.S. equity indices declined across the board, with the Nasdaq-100 falling 5.0% and the S&P 500 down 2.7%, while the Dow Jones lost just 1.0%. Breadth was nearly balanced, with 934 advancers against 961 decliners among the 1,910 stocks screened.

Index & Asset Scoreboard

Weekly price change of the major index and asset-class ETFs, Friday close to Friday close.

InstrumentNov 6 closeWeek
S&P 500 (SPY)$735.36▼-2.69%
Nasdaq-100 (QQQ)$656.10▼-4.98%
Dow Jones (DIA)$512.22▼-0.95%
Russell 2000 (IWM)$273.64▼-2.04%
20+ Yr Treasuries (TLT)$81.92▲+0.10%
Gold (GLD)$372.58▲+4.72%
Crude Oil (USO)$148.41▼-12.10%

Sector Rotation

Real estate and consumer discretionary each gained 1.9% to lead all sectors, while technology fell 8.2% and energy dropped 12.0% to lag. Breadth inside the leading sectors confirmed the rotation: 74 of 107 real estate names rose, and 141 of 211 consumer discretionary stocks advanced.

Left: the ten SPDR sector ETFs ranked by weekly price change. Right: breadth inside each sector across the screened universe: how many of its stocks rose, and the average move.

Sector ETFWeek
Real Estate (XLRE)▲+1.92%
Consumer Disc. (XLY)▲+1.91%
Financials (XLF)▲+1.15%
Consumer Staples (XLP)▲+0.74%
Health Care (XLV)▼-0.04%
Utilities (XLU)▼-0.69%
Materials (XLB)▼-1.50%
Industrials (XLI)▼-2.81%
Technology (XLK)▼-8.23%
Energy (XLE)▼-12.00%
Sector (stocks)Adv / TotalAvg move
Communication45 / 64+3.35%
Real Estate74 / 107+1.94%
Consumer Staples58 / 86+1.81%
Consumer Discretionary141 / 211+1.66%
Financials192 / 337+0.81%
Health Care151 / 283+0.32%
Utilities34 / 60+0.19%
Materials42 / 93-1.18%
Industrials131 / 311-1.68%
Information Technology61 / 261-6.47%
Energy4 / 96-14.34%

Standout Movers

Earnings beats drove the largest gains, led by AppLovin Corporation, which rose 71.2% after reporting an earnings surprise, and Unity Software Inc., which gained 36.6% following an earnings beat of 688.5%. Large-cap healthcare names also outperformed after their own beats.

The largest decliners were concentrated in information technology hardware and healthcare. Seagate Technology Holdings PLC fell 28.5%, and Veracyte, Inc. dropped 51.7% despite an earnings beat.

Top 10 Winners

Largest weekly gains among US-listed stocks with market cap above $1B and share price above $5. Context shows the week's earnings result and latest headline where available.

Biggest gainers · Oct 30–Nov 6

SymbolWeekContext
APPAppLovin Corporation$391.22▲+71.21%
EPS beat +5.4%
CRCTCricut, Inc.$8.78▲+44.41%
EPS beat +181.4%
ARDTArdent Health Inc$17.30▲+43.81%
EPS beat +40.5%
XERSXeris Biopharma Holdings, Inc.$15.20▲+41.92%
EPS beat +144.9%
SHLSShoals Technologies Group Inc$10.08▲+40.00%
—
UUnity Software Inc.$51.49▲+36.58%
EPS beat +688.5%
ENOVEnovis Corporation$27.16▲+36.41%
EPS beat +12.1%
VCELVericel Corporation$54.62▲+35.67%
EPS beat +360.0%
BETABETA Technologies, Inc.$27.12▲+35.26%
EPS beat +14.8%
TMDXTransMedics Group, Inc.$88.24▲+33.72%
EPS beat +71.3%

Top 10 Losers

Largest weekly declines on the same screen.

Biggest decliners · Oct 30–Nov 6

SymbolWeekContext
VCYTVeracyte, Inc.$24.16▼-51.69%
EPS beat +21.8%
NRIXNurix Therapeutics, Inc.$15.30▼-42.91%
—
AESIAtlas Energy Solutions Inc.$5.41▼-41.32%
EPS miss -52.2%
KRTKarat Packaging Inc$33.54▼-37.85%
EPS miss -42.5%
SUPNSupernus Pharmaceuticals, Inc.$26.16▼-37.60%
—
LITELumentum Holdings Inc.$538.59▼-35.94%
—
CVICVR Energy Inc$38.13▼-34.68%
EPS beat +62.8%
DOXAmdocs Limited$42.09▼-33.01%
—
FSLYFastly, Inc.$15.85▼-31.43%
EPS beat +40.5%
SNDXSyndax Pharmaceuticals, Inc.$9.54▼-30.11%
EPS miss -9.6%

Large-Cap Movers

The same ranking restricted to companies above $50B in market cap: the names most likely to sit in index funds and 401(k)s.

Large-cap gainers

  • APPAppLovin Corporation · $85.3B
    ▲+71.21%
  • MDLNMedline Inc. · $52.3B
    ▲+23.41%
  • IDXXIDEXX Laboratories, Inc. · $55.0B
    ▲+22.65%
  • ABNBAirbnb, Inc. · $99.7B
    ▲+15.57%
  • MRNAModerna, Inc. · $101.5B
    ▲+14.64%

Large-cap decliners

  • STXSeagate Technology Holdings PLC · $146.5B
    ▼-28.48%
  • MRVLMarvell Technology, Inc. · $123.8B
    ▼-28.11%
  • WDCWestern Digital Corp · $128.6B
    ▼-27.95%
  • SNDKSanDisk Corporation · $181.5B
    ▼-27.44%
  • ALABAstera Labs, Inc. · $50.4B
    ▼-26.28%

Earnings Movers

Post-earnings reactions were mixed, with large beats often rewarded but beats alone not guaranteeing gains. AppLovin Corporation rose 71.2% after an earnings surprise, while Veracyte, Inc. fell 51.7% despite beating estimates by 21.8%.

741 companies in the screen reported quarterly results this week. These are the largest weekly moves among them, with the EPS surprise that accompanied them.

Biggest gains after reporting

SymbolAct / EstSurpriseWeek
APPAppLovin Corporation$4.30$4.08+5.4%▲+71.21%
CRCTCricut, Inc.$0.13$0.05+181.4%▲+44.41%
ARDTArdent Health Inc$0.31$0.22+40.5%▲+43.81%
XERSXeris Biopharma Holdings, Inc.$0.06$0.02+144.9%▲+41.92%
UUnity Software Inc.$0.44$0.06+688.5%▲+36.58%

Biggest declines after reporting

SymbolAct / EstSurpriseWeek
VCYTVeracyte, Inc.$0.51$0.42+21.8%▼-51.69%
AESIAtlas Energy Solutions Inc.$-0.36$-0.24-52.2%▼-41.32%
KRTKarat Packaging Inc$0.24$0.42-42.5%▼-37.85%
CVICVR Energy Inc$4.00$2.46+62.8%▼-34.68%
FSLYFastly, Inc.$0.17$0.12+40.5%▼-31.43%

Analyst Sentiment Shifts

Week-over-week change in the share of analysts rating a stock Buy or Strong Buy (minimum five covering analysts).

Buy share rising

SymbolAnalystsBuy share nowChange (pp)
PAHCPhibro Animal Health Corp966.7%▲+55.6%
IIPRInnovative Industrial Properties Inc1457.1%▲+48.1%
GEFGreif Inc955.6%▲+47.9%
NTRSNorthern Trust Corporation2236.4%▲+26.4%
BAHBooz Allen Hamilton Holding Corporation2138.1%▲+25.6%

Buy share falling

SymbolAnalystsBuy share nowChange (pp)
BRZEBraze, Inc.2626.9%▼-69.5%
OPCHOption Care Health Inc160.0%▼-68.4%
BBAIBigBear.ai Holdings, Inc.70.0%▼-66.7%
PCRXPacira Biosciences Inc140.0%▼-66.7%
CCCCCC Intelligent Solutions Holdings Inc.1811.1%▼-63.9%

Methodology & Disclaimer

Data. All figures come from Money365.Market's own daily price, earnings and analyst-recommendation records, captured at each US close. Returns are price returns from the Oct 30 close to the Nov 6 close; dividends are excluded.

Screen. 1,910 US-listed common stocks with market capitalization of at least $1B and a closing price of at least $5, with prices on at least three of the week's 5 trading days. ETFs and funds are excluded from the stock rankings.

Adjustments. Weekly moves are compounded from daily changes and cross-checked against closing prices; where the two disagree (stock splits, data corrections) the smaller move is used and the row is marked with an asterisk.

Narrative. The short prose sections were drafted by an AI model from the verified data above only, then checked automatically for number and ticker traceability, editorial tone and FCA financial-promotion wording before publication.

Important Disclaimer — Not Investment Advice

Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.

Read the full disclaimer — 8 further points, including total-loss risk, our regulatory status and conflicts of interest

Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.

  • You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
  • Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
  • Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
  • Automated content. This brief was compiled by an automated pipeline from validated news and market-data sources and passed through editorial and compliance checks. Automated content can still contain errors — verify anything you intend to rely on.
  • We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
  • Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
  • Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.

Full terms: Disclaimer · Terms of Service · Privacy Policy